Real People's Stories

Scientific Progress

Take action

News

Reaching milestones.

Watch our founder and chairman Robert Klein speak on the successes of stem cell research over the last decade since Proposition 71.

Learn more

Real Stories. Real People.

While the patients here have agreed to participate, we ask that their privacy is respected. Please do not contact them directly but rather place any requests through Americans for Cures.

Scientific Advisory Board

a1

Aileen Anderson, Ph.D.

University of California, Irvine

a19

Maria Grazia Roncarolo, MD

Stanford University

a3

Gay Crooks, M.B.B.S.

University of California, Los Angeles

a4

Rusty Gage, Ph.D.

The Salk Institute for Biological Studies

a5

Larry Goldstein, Ph.D.

University of California, San Diego

 

a6

Catriona Jamieson, MD, Ph.D

University of California, San Diego

a7

Brian Kennedy, Ph.D.

Buck Institute for Research on Aging

a8

Donald Kohn, MD

University of California, Los Angeles

a9

Arnold Kriegstein, MD, Ph.D.

University of California, San Francisco

a10

Andy McMahon, Ph.D.

University of Southern California 

 

a11

Phil Pizzo, MD

Stanford University

a12

David Schaffer, Ph.D.

University of California at Berkeley

a13

Judith Shizuru, MD, Ph.D.

Stanford University

a14

Evan Snyder, MD, Ph.D.

Sanford-Burnham Medical Research Institute

a15

Deepak Srivastava, MD

Gladstone Institutes

 

a16

Clive Svendsen, Pd.D

Cedars-Sinai Medical Center

a17

Irv Weissman, MD

Stanford University

a18

Owen Witte, MD

University of California, Los Angeles

a20

Samuel Cheshier, MD, Ph.D

Stanford University

a21

Kelly A. Frazer, Ph.D.

University of California, San Diego

Making progress.

 

Milestones of Progress Spotlight

Milestones

Here are some of the successes that the public investment in stem cell research has achieved over the last decade.



Age Related Macular Degeneration


Age-related macular degeneration (AMD) is a common eye condition and the leading loss of vision in people over 50 years old, affecting over 2 million Americans. Treatments using embryonic stem cells may be able to restore functional vision to people suffering from AMD.


Breast Cancer

About 1 in 8 American women will develop invasive breast cancer over the course of their lifetimes. Chemotherapy and radiation have long been the standard, aggressive treatments for breast cancer and other types of cancer. However, cancer researchers funded by California’s stem cell agency have made a groundbreaking discovery that could dramatically improve survival rates for women with metastatic breast cancer.



Type 1 Diabetes

Type 1 Diabetes arises when a person’s own immune system mistakenly kills the insulin-producing beta cells in the pancreas. In the United States alone, Type 1 diabetes patients self-administer eleven million insulin injections daily to manage their illness, and California has the largest population of people afflicted with diabetes. Stem cell researchers are finding ways to reduce intensity of diabetes treatment schedules—or even possibly cure the disease altogether.



Sickle Cell

Sickle cell disease is an agonizing and often-fatal genetic disorder resulting from a mutation of red blood cells that disproportionately affect the African American and Hispanic communities. Research funded by California’s stem cell agency may have found the key to genetically correct cells to prevent this mutation, a possible permanent cure.



Spinal Cord Injury

Damage to the spinal cord from trauma, disease, or degeneration can lead to partial or complete loss of sensory function or motor control of arms, legs and/or body and chronic pain. Researchers are finding that stem cells may be used to create “scaffolding” across which nerves can grow, restoring some movement to people with spinal cord injuries.



Overview

Age Related Macular Degeneration (Blindness)

Breast Cancer

Diabetes

Sickle Cell Disease

Spinal Cord Injury

What's new at AFC